Overview

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This study will evaluate the safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM) who are receiving background treatment with pioglitazone.

Phase:

Phase 3

Details

Lead Sponsor:

Forest Laboratories

Collaborator:

Phenomix

Treatments:

Pioglitazone